X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (119) 119
index medicus (115) 115
hypertension (72) 72
female (71) 71
male (67) 67
middle aged (55) 55
peripheral vascular disease (53) 53
aged (46) 46
adult (40) 40
hypertension - drug therapy (39) 39
risk factors (38) 38
mortality (35) 35
angiotensin-converting enzyme inhibitors - therapeutic use (30) 30
pharmacology & pharmacy (29) 29
blood pressure - drug effects (28) 28
myocardial infarction - drug therapy (28) 28
cardiac & cardiovascular systems (27) 27
drug therapy (25) 25
captopril (24) 24
antihypertensive agents - therapeutic use (23) 23
captopril - analogs & derivatives (23) 23
hypertension - physiopathology (23) 23
medicine & public health (22) 22
captopril - therapeutic use (21) 21
cardiology (21) 21
double-blind method (19) 19
blood pressure (18) 18
blood-pressure (18) 18
heart attack (18) 18
hypertension - complications (18) 18
pharmacotherapy (18) 18
angiotensin-converting enzyme inhibitors (17) 17
abridged index medicus (16) 16
ace inhibitors (16) 16
acute myocardial infarction (16) 16
cardiovascular risk (16) 16
morbidity (16) 16
heart failure (15) 15
treatment outcome (15) 15
adolescent (14) 14
care and treatment (14) 14
drug therapy, combination (14) 14
myocardial infarction (14) 14
zofenopril (14) 14
ace-inhibitors (13) 13
captopril - administration & dosage (13) 13
hypertension - diagnosis (13) 13
italy - epidemiology (13) 13
prevalence (13) 13
survival (13) 13
enzymes (12) 12
left-ventricular dysfunction (12) 12
therapy (12) 12
analysis (11) 11
angiotensin-converting enzyme inhibitors - administration & dosage (11) 11
clinical trials as topic (11) 11
heart attacks (11) 11
hypertension - epidemiology (11) 11
angiotensin (10) 10
blood pressure - physiology (10) 10
captopril - pharmacology (10) 10
double-blind (10) 10
europe (10) 10
time factors (10) 10
angiotensin-converting enzyme inhibitors - pharmacology (9) 9
antihypertensive treatment (9) 9
arterial hypertension (9) 9
borderline hypertension (9) 9
cardiovascular system (9) 9
electrocardiography (9) 9
hypertension - blood (9) 9
myocardial infarction - mortality (9) 9
risk (9) 9
trial (9) 9
aged, 80 and over (8) 8
angiotensin-converting enzyme inhibitors - adverse effects (8) 8
antihypertensive therapy (8) 8
cardiovascular disease (8) 8
converting-enzyme-inhibitors (8) 8
guidelines (8) 8
health aspects (8) 8
heart-failure (8) 8
lisinopril (8) 8
medicine, general & internal (8) 8
metabolic syndrome (8) 8
ramipril (8) 8
renin - blood (8) 8
research (8) 8
stroke (8) 8
acute myocardial-infarction (7) 7
captopril - adverse effects (7) 7
cardiac patients (7) 7
cardiovascular diseases - epidemiology (7) 7
cardiovascular diseases - prevention & control (7) 7
cardiovascular-disease (7) 7
clinical trials (7) 7
converting-enzyme-inhibitor (7) 7
cross-sectional studies (7) 7
diagnosis (7) 7
heart failure - drug therapy (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 2006, Volume 66, Issue 7, pp. 970 - 971
Journal Article
American Heart Journal, ISSN 0002-8703, 2007, Volume 153, Issue 3, pp. 445.e7 - 445.e14
Journal Article
Circulation, ISSN 0009-7322, 10/2009, Volume 120, Issue 16, pp. 1598 - 1605
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2014, Volume 9, Issue 11, pp. e111558 - e111558
Journal Article
by Mancia, Giuseppe and Fagard, Robert and Narkiewicz, Krzysztof and Redon, Josep and Zanchetti, Alberto and Böhm, Michael and Christiaens, Thierry and Cifkova, Renata and De Backer, Guy and Dominiczak, Anna and Galderisi, Maurizio and Grobbee, Diederick E and Jaarsma, Tiny and Kirchhof, Paulus and Kjeldsen, Sverre E and Laurent, Stéphane and Manolis, Athanasios J and Nilsson, Peter M and Ruilope, Luis Miguel and Schmieder, Roland E and Sirnes, Per Anton and Sleight, Peter and Viigimaa, Margus and Waeber, Bernard and Zannad, Faiez and Burnier, Michel and Ambrosioni, Ettore and Caufield, Mark and Coca, Antonio and Olsen, Michael Hecht and Tsioufis, Costas and Van De Borne, Philippe and Zamorano, Jose Luis and Achenbach, Stephan and Baumgartner, Helmut and Bax, Jeroen J and Bueno, Héctor and Dean, Veronica and Deaton, Christi and Erol, Cetin and Ferrari, Roberto and Hasdai, David and Hoes, Arno W and Knuuti, Juhani and Kolh, Philippe and Lancellotti, Patrizio and Linhart, Ales and Nihoyannopoulos, Petros and Piepoli, Massimo F and Ponikowski, Piotr and Tamargo, Juan Luis and Tendera, Michal and Torbicki, Adam and Wijns, William and Windecker, Stephan and Clement, Denis L and Gillebert, Thierry C and Rosei, Enrico Agabiti and Anker, Stefan D and Bauersachs, Johann and Hitij, Jana Brguljan and Caulfield, Mark and De Buyzere, Marc and De Geest, Sabina and Derumeaux, Geneviève Anne and Erdine, Serap and Farsang, Csaba and Funck-Brentano, Christian and Gerc, Vjekoslav and Germano, Giuseppe and Gielen, Stephan and Haller, Herman and Jordan, Jens and Kahan, Thomas and Komajda, Michel and Lovic, Dragan and Mahrholdt, Heiko and Ostergren, Jan and Parati, Gianfranco and Perk, Joep and Polonia, Jorge and Popescu, Bogdan A and Reiner, Željko and Rydén, Lars and Sirenko, Yuriy and Stanton, Alice and Struijker-Boudier, Harry and Vlachopoulos, Charalambos and Volpe, Massimo and Wood, David A and Linnéuniversitetet and Institutionen för hälso- och vårdvetenskap (HV) and Fakulteten för Hälso- och livsvetenskap (FHL)
European Heart Journal, ISSN 0195-668X, 07/2013, Volume 34, Issue 28, pp. 2159 - 2219
Blood pressure measurement | Hypertension | Organ damage | Cardiovascular risk | Antihypertensive treatment | Device therapy | Lifestyle | Blood pressure | Cardiovascular complications | Follow-up | Guidelines | Physical Examination - methods | Humans | Middle Aged | Patient Care Team | Heart Diseases - prevention & control | Male | Sleep Apnea, Obstructive - complications | Hormone Replacement Therapy - adverse effects | Young Adult | Drug Interactions | Cerebrovascular Disorders - prevention & control | Retinal Diseases - etiology | Electrocardiography | Renal Insufficiency, Chronic - diagnosis | Brain Diseases - etiology | Contraceptives, Oral - adverse effects | Hypertension - therapy | Cardiovascular Diseases - diagnosis | Cardiovascular Diseases - etiology | Hyperglycemia - prevention & control | Retinal Diseases - diagnosis | Sexual Dysfunction, Physiological - prevention & control | Echocardiography | Risk Assessment | Brain Diseases - diagnosis | Risk Factors | Antihypertensive Agents - therapeutic use | Metabolic Syndrome - complications | Sexual Dysfunction, Physiological - etiology | Diet | Perioperative Care - methods | Exercise - physiology | Smoking Cessation | Renal Insufficiency, Chronic - etiology | Cerebrovascular Disorders - complications | Adult | Female | Blood Pressure - physiology | Drug Therapy, Combination | Hypertension - diagnosis | Platelet Aggregation Inhibitors - therapeutic use | Risk Reduction Behavior | Hypertension, Pregnancy-Induced - diagnosis | Diabetes Complications - complications | Pregnancy | Delivery of Health Care | Medical Informatics | Weight Loss | Aged | Blood Pressure Monitoring, Ambulatory | Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Hälsovetenskap | Medical and Health Sciences | Medicin och hälsovetenskap | Health and Caring Sciences | Klinisk medicin
Journal Article
Drugs, ISSN 0012-6667, 2006, Volume 66, Issue 7, p. 971
Journal Article
Journal of Hypertension, ISSN 0263-6352, 11/2009, Volume 27, Issue 11, pp. 2121 - 2158
Journal Article
Clinical Cardiology, ISSN 0160-9289, 2012, Volume 35, Issue 7, pp. 416 - 423
Background: Angiotensin-converting enzyme inhibitors (ACEIs) are largely employed for treating patients with left ventricular dysfunction (LVD), but their... 
MORTALITY | ACE-INHIBITORS | CARDIAC & CARDIOVASCULAR SYSTEMS | TASK-FORCE | MORBIDITY | PROSTAGLANDINS | HEART-FAILURE | CARDIOVASCULAR-DISEASE | ASPIRIN | CONVERTING-ENZYME-INHIBITORS | BRADYKININ | Myocardial Infarction - mortality | Prospective Studies | Humans | Middle Aged | Heart Failure - physiopathology | Systole - drug effects | Male | Ventricular Dysfunction, Left - mortality | Captopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Time Factors | Aspirin - adverse effects | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Female | Aspirin - therapeutic use | Captopril - adverse effects | Ramipril - therapeutic use | Drug Therapy, Combination | Odds Ratio | Platelet Aggregation Inhibitors - therapeutic use | Ramipril - adverse effects | Captopril - analogs & derivatives | Heart Failure - etiology | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Risk Assessment | Europe | Risk Factors | Ventricular Function, Left - drug effects | Kaplan-Meier Estimate | Stroke Volume - drug effects | Ventricular Dysfunction, Left - etiology | Logistic Models | Treatment Outcome | Hospitalization | Chi-Square Distribution | Ventricular Dysfunction, Left - physiopathology | Heart Failure - drug therapy | Myocardial Infarction - complications | Ventricular Dysfunction, Left - drug therapy | Aged | Confidence intervals | Heart failure | Heart attacks | Drug therapy | Mortality | Index Medicus
Journal Article
Journal Article